Liberum Biotech is a seed-stage venture that focuses on accelerating enzyme and antibody discovery through its cutting-edge proprietary cell-free protein synthesis platform. Founded in 2019, it operates within the biotechnology and manufacturing industries. The company recently secured a significant $1.80M Seed Round investment on 24 July 2023 from prominent investors such as SOSV, TechU Ventures, and Savantus Ventures. With its forward-looking approach and innovative technology, Liberum Biotech, also known as "The Protein Discovery Company," is poised to make a profound impact in the biotech industry landscape.
No recent news or press coverage available for Liberum Biotech.